Product Images Tosymra
View Photos of Packaging, Labels & Appearance
Product Label Images
The following 15 images provide visual information about the product associated with Tosymra NDC 0245-0812 by Upsher-smith Laboratories, Llc, such as packaging, labeling, and the appearance of the drug itself. This resource could be helpful for medical professionals, pharmacists, and patients seeking to verify medication information and ensure they have the correct product.
Chemical Structure - tosymra 01
Figure A - tosymra 02
The text refers to a diagram of a spray nozzle, indicating the different parts of the nozzle, including the tip, plunger, and spray nozzle. It is not providing any further explanation or context.*
Figure B - tosymra 03
Figure C - tosymra 04
Figure D - tosymra 05
Figure E - tosymra 06
Figure F - tosymra 07
Figure G - tosymra 08
Figure H - tosymra 09
Figure I - tosymra 10
Figure J - tosymra 11
Figure K - tosymra 12
Figure L - tosymra 13
The text describes a breathing exercise with the instruction to breathe in gently through the nose and breathe out through the mouth. There is also a reference to "Figure L" which is not providing any context for what it refers to.*
Figure M - tosymra 14
PRINCIPAL DISPLAY PANEL - 6 Bottle Blister Pack Carton - tosymra 15
This is a prescription drug, Sumatriptan nasal spray, used to treat migraines. This package contains six unit-dose nasal spray devices, each containing 10mg of sumatriptan in 0.1 mL, a prescribing information leaflet, and an instructions for use leaflet. It should be stored at room temperature and kept out of reach of children. The usual dosage information is provided in the package insert. Manufactured by Upsher Smith Laboratories, LLC. TOSYMRA is a registered trademark of Upsher Smith Laboratories, LLC.*
* The product label images have been analyzed using a combination of traditional computing and machine learning techniques. It should be noted that the descriptions provided may not be entirely accurate as they are experimental in nature. Use the information in this page at your own discretion and risk.